Clinical Trial Details


Back to Clinical Trials Database

A randomized phase III multicenter trial of neoadjuvant docetaxel (Taxotere) plus cisplatin plus 5-fluorouracil versus neoadjuvant cisplatin plus 5-fluorouracil in patients with locally advanced inoperable squamous cell carcinoma of the head and neck

Study documentation

Trial Status All trial activities ended
Dates Date of activation: 13-Apr-1999
Date Step1 close: 15-Mar-2002
Data management at EORTC Yes
Design Phase 3
Randomized open label
Targeted Sample size EORTC Groups: 348
Study Staff
Type of cancer
Participating groups
Protocol summary
NCT number NCT00003888